Results 121 to 130 of about 428 (162)

A case of sialodochitis fibrinosa with MR findings leading to selection of an appropriate treatment. [PDF]

Radiol Case Rep
Inoue A, Ikeda K, Goto T, Hashimoto K.
europepmc   +1 more source

Preliminary Analysis of Drug-Induced Ototoxicity in South Korea: Trends From a National Sample Dataset. [PDF]

J Audiol Otol
Aldahan Z, Kim J, Yoon CY, Seo YJ, Park KH.   +4 more
europepmc   +1 more source

Synthesis of polysubstituted cyclobutanes through a photoredox strain-release/[3,3]-rearrangement cascade. [PDF]

Chem Sci
Zhang F, Xu C, Zhang Z, Yang Z, Peng T, Shao W, Feng X, Liu Y.   +7 more
europepmc   +1 more source

Drug Sensitivity Testing in Osteosarcoma: A Case Report. [PDF]

Curr Oncol
Lohse I, Dutcher G, Al-Ali H, Alperstein W, Coulter DW, Trucco M, Trent JC, Wahlestedt C.   +7 more
europepmc   +1 more source

Design and in vivo pharmacokinetic evaluation of a once-daily immediate- and extended-release bilayer tablet of bepotastine salicylate

Do Hwan Kim, In Gyu Yang, Wookyung Kim, Myung Joo Kang, Sun Ho Kim, Jinsu Yang, Min Young Jeong, Seonyeong Jeong   +7 more
core   +1 more source

Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate

Current Medical Research and Opinion, 2010
The purpose of this review is to examine published non-clinical literature on the antihistamine bepotastine besilate, including pharmacokinetic and pharmacologic properties.Standard literature searches using diverse databases were used to find articles on bepotastine besilate published between 1997 and 2009.
Jon I, Williams, James A, Gow, Sharon M, Klier, Shannon L, McCue, Anne Marie F, Salapatek, Timothy R, McNamara   +5 more
exaly   +4 more sources

Characterization of Photodegradation Products of Bepotastine Besilate and In Silico Evaluation of Their Physicochemical, Absorption, Distribution, Metabolism, Excretion and Toxicity Properties

Journal of Pharmaceutical Sciences, 2020
Bepotastine (BPT) is a H1-receptor antagonist. It is used as a besilate salt in ophthalmic solution for allergic conjunctivitis and orally for the treatment of allergic rhinitis and urticaria/pruritus.
Asit Chakraborti, Prasad V Bharatam, Saranjit Singh   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Bepotastine besilate for the treatment of perennial allergic rhinitis

Expert Opinion on Pharmacotherapy, 2018
Bepotastine besilate (BB) is a second-generation H1-antihistamine that, as an ophthalmic solution, is approved in the United States by the Food and Drug Administration (FDA) for the treatment of allergic conjunctivitis. In other countries, the oral presentation of BB is widely used for the improvement of symptoms of allergic rhinitis (AR) as well as ...
Alexei Gonzalez-Estrada, Ismael Carrillo-Martin   +1 more
exaly   +3 more sources

Improved Synthesis of Bepotastine Besilate

Organic Preparations and Procedures International, 2021
Bepotastine besilate (1, Figure 1, synonymous with bepotastine besylate), is a non-sedative highly selective histamine receptor antagonist, which has a stabilizing effect on mast cells.
C. Q. Han, Y. Y. Xia, Q. Sun, Q. G. Zou
openaire   +1 more source